# Lonza Biologics (Lonza Biologics PLC)

Public limited company registered in Berkshire, classed under “Other service activities n.e.c.”.

- Company number: 02742471
- Status: Active
- Type: Public limited company
- Incorporated: 25 August 1992
- Registered office: 228 Bath Road, Slough, Berkshire, SL1 4DX
- Location: Berkshire
- Activity: Other service activities n.e.c.

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Lonza Biologics do?

Public limited company registered in Berkshire, classed under “Other service activities n.e.c.”.

### How much turnover does Lonza Biologics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/lonza-biologics-02742471

### Is Lonza Biologics profitable?

Lonza Biologics's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Lonza Biologics?

Its directors are Richard Paul Coop, Ralf Manfred Geier-Cibin, Johann Claude Schwaller, Martin Wrankmore. Its owners are shown to subscribers.

### Where is Lonza Biologics based?

Its registered office is 228 Bath Road, Slough, Berkshire, SL1 4DX, in Berkshire.

### When was Lonza Biologics founded?

Lonza Biologics PLC was incorporated on 25 August 1992.

### Is Lonza Biologics still trading?

The register lists Lonza Biologics PLC as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-09: Full accounts made up to 31 December 2025
- 2025-06-17: Full accounts made up to 31 December 2024
- 2024-11-11: Termination of appointment of Edward Garfield as a director on 8 November 2024
- 2024-08-22: Director's details changed for Ralf Manfred Geier-Cibin on 21 August 2024
- 2024-08-22: Director's details changed for Mr Edward Garfield on 21 August 2024
- 2024-08-21: Director's details changed for Martin Wrankmore on 21 August 2024
- 2024-07-11: Full accounts made up to 31 December 2023
- 2024-06-13: Appointment of Johann Claude Schwaller as a director on 1 May 2024
- 2024-06-12: Termination of appointment of Sandeepan Chakrawertti as a director on 1 May 2024
- 2024-04-26: Appointment of Richard Paul Coop as a secretary on 26 April 2024
- 2024-04-26: Termination of appointment of Gerard Kennedy as a secretary on 26 April 2024
- 2023-11-23: Appointment of Martin Wrankmore as a director on 1 November 2023
- 2023-11-22: Termination of appointment of Alexander Herget as a director on 31 October 2023
- 2023-10-05: Full accounts made up to 31 December 2022
- 2023-02-13: Full accounts made up to 31 December 2021
- 2021-10-04: Full accounts made up to 31 December 2020
- 2021-07-05: Appointment of Sandeepan Chakrawertti as a director on 1 July 2021
- 2021-07-01: Termination of appointment of Nick Carter as a director on 1 July 2021
- 2021-01-07: Full accounts made up to 31 December 2019
- 2020-05-28: Director's details changed for Mr Nick Carter on 28 May 2020
- 2020-05-27: Appointment of Alexander Herget as a director on 21 May 2020
- 2020-05-27: Termination of appointment of Michael Edward Brown as a director on 21 May 2020
- 2019-07-10: Full accounts made up to 31 December 2018
- 2018-08-02: Appointment of Ralf Manfred Geier-Cibin as a director on 16 July 2018
- 2018-07-27: Termination of appointment of Rodolfo Savitzky as a director on 16 July 2018

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/lonza-biologics-02742471